Related Experiment Video
Updated: Jul 19, 2026

11:29
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Purine metabolism in B-cell lymphocytic leukemia: a microarray approach
E Marinello1, F Carlucci, F Rosi
1Department of Internal Medicine, Endocrine-Metabolic Sciences and Biochemistry, University of Siena, Siena, Italy. carlucci@unisi.it
Nucleosides, Nucleotides & Nucleic Acids
|October 27, 2006
Summary
This study investigated purine metabolism in B-cell chronic lymphocytic leukemia (B-CLL), finding altered gene expression in purine pathways. These findings suggest a role for purine metabolism in B-CLL apoptosis resistance.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- B-cell chronic lymphocytic leukemia (B-CLL) is an adult malignancy characterized by resistance to apoptosis.
- Previous research indicated an imbalance in purine metabolism within B-CLL cells.
- Extracellular adenosine can induce apoptosis via the A2b receptor, suggesting a role for adenosine metabolism enzymes in B-CLL apoptosis resistance.
Purpose of the Study:
- To analyze gene expression profiles related to purine metabolism and apoptosis in B-CLL.
- To identify potential therapeutic targets by understanding the role of purine metabolism in B-CLL pathogenesis.
Main Methods:
- Development and application of a microarray chip for analyzing 50 selected genes.
- Genes included enzymes from purine de novo, salvage, and catabolic pathways, oxidative stress enzymes, and apoptosis-related proteins.
Main Results:
- Preliminary results revealed significant alterations in the expression of numerous purine metabolism genes.
- Genes involved in signal transduction and apoptosis showed less pronounced alterations.
- The microarray technique proved promising for identifying candidate genes in B-CLL.
Conclusions:
- Gene expression profiling of purine metabolism in B-CLL is a promising approach.
- Altered purine metabolism gene expression may contribute to apoptosis resistance in B-CLL.
- A subset of identified genes warrants further investigation as potential therapeutic targets.

